The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET

BACKGROUND: Non-invasive diagnosis of IDH1 mutation for gliomas has great clinical significance, and PET has natural advantage to detect metabolism, as IDH mutated gliomas share lower glucose consumption. METHODS: Clinical data of patients with gliomas and (18)F-FDG PET were retrospectively reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feng-Min, Gao, Yu-fei, Kong, Yanyan, Guan, Yihui, Zhang, Jinsen, Li, Shuai-Hong, Ye, Dan, Wen, Wenyu, Zuo, Chuantao, Hua, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816361/
https://www.ncbi.nlm.nih.gov/pubmed/33472598
http://dx.doi.org/10.1186/s12885-021-07797-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816361/
https://www.ncbi.nlm.nih.gov/pubmed/33472598
http://dx.doi.org/10.1186/s12885-021-07797-6

Ejemplares similares